Antibody persistence following meningococcal ACWY conjugate vaccine licensed in the European Union by age group and vaccine.

Adult Age Factors Animals Antibody Formation / immunology Child, Preschool European Union Humans Immunogenicity, Vaccine Infant Meningococcal Infections / immunology Meningococcal Vaccines / administration & dosage Neisseria meningitidis / immunology Rabbits Randomized Controlled Trials as Topic Vaccination
MenACWY-CRM197 MenACWY-TT antibody persistence conjugate vaccines meningococcal

Journal

Expert review of vaccines
ISSN: 1744-8395
Titre abrégé: Expert Rev Vaccines
Pays: England
ID NLM: 101155475

Informations de publication

Date de publication:
08 2020
Historique:
pubmed: 9 9 2020
medline: 1 4 2021
entrez: 8 9 2020
Statut: ppublish

Résumé

Meningococcal disease caused by Randomized trials showed that MenACWY-TT is immunogenic at all ages. MenACWY-CRM MenACWY-TT and MenACWY-CRM

Identifiants

DOI: 10.1080/14760584.2020.1800460 PMID: 32897762
pubmed: 32897762
doi: 10.1080/14760584.2020.1800460
doi:

Substances chimiques

MenACWY-CRM vaccine 0
Meningococcal Vaccines 0
tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine 0

Types de publication

Comparative Study Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

745-754

Auteurs

Weichang Luo (W)

Royal Manchester Children's Hospital, University of Manchester , Manchester, UK.

Peter D Arkwright (PD)

Royal Manchester Children's Hospital, Lydia Becker Institute of Immunology and Inflammation, University of Manchester , Manchester, UK.

Ray Borrow (R)

Vaccine Evaluation Unit, Public Health England, Manchester Royal Infirmary , Manchester, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Antibody persistence following meningococcal...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Facteurs épidémiologiques › Facteurs âges › Antibody persistence following meningococcal...
questionsmedicales.fr › Eucaryotes › Animaux › Antibody persistence following meningococcal...
questionsmedicales.fr › Phénomènes du système immunitaire › Immunité › Immunité acquise › Immunité active › Production d'anticorps › Antibody persistence following meningococcal...
questionsmedicales.fr › Personnes › Tranches d'âge › Enfant › Enfant d'âge préscolaire › Antibody persistence following meningococcal...
questionsmedicales.fr › Sciences sociales › Internationalité › Coopération internationale › Union européenne › Antibody persistence following meningococcal...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Antibody persistence following meningococcal...
questionsmedicales.fr › Phénomènes du système immunitaire › Immunogénicité des vaccins › Antibody persistence following meningococcal...
questionsmedicales.fr › Personnes › Tranches d'âge › Nourrisson › Antibody persistence following meningococcal...
questionsmedicales.fr › Infection › Infections bactériennes et mycoses › Infections bactériennes › Infections bactériennes à Gram négatif › Infections à Neisseriaceae › Infections à méningocoques › Antibody persistence following meningococcal...
questionsmedicales.fr › Mélanges complexes › Produits biologiques › Vaccins › Vaccins antibactériens › Vaccins antiméningococciques › Antibody persistence following meningococcal...
questionsmedicales.fr › Bactéries › Proteobacteria › Betaproteobacteria › Neisseriaceae › Neisseria › Neisseria meningitidis › Antibody persistence following meningococcal...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Lagomorpha › Lapins › Antibody persistence following meningococcal...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études cliniques comme sujet › Essais cliniques comme sujet › Essais cliniques contrôlés comme sujet › Essais contrôlés randomisés comme sujet › Antibody persistence following meningococcal...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Pratiques en santé publique › Prévention primaire › Immunisation › Vaccination › Antibody persistence following meningococcal...